
    
      study will include the following:

        -  sex

        -  age

        -  BMI

        -  ethnicity

        -  age diagnosed with Myeloproliferative disease

        -  clinical manifestations of the myeloproliferative disease

        -  JAK2 mutation

        -  known hematological complications
    
  